How Does Ketamine Therapy Work for Depression?
According to the National Institute of Mental Health, major depression affects more than 21 million adults in the United States every year. For many of them, standard antidepressants never fully work. Some people cycle through multiple medications over months or years, managing side effects while waiting for relief that never comes. If that sounds familiar, ketamine therapy for depression may be worth understanding in full.
This guide covers the science behind how ketamine works differently than conventional antidepressants, what the treatment experience looks like at BioFuse, who is a candidate, and where to get started in Michigan and Idaho.
Why Conventional Antidepressants Fall Short for So Many People
Most antidepressants work by adjusting serotonin, norepinephrine, or dopamine levels in the brain. They can take six to twelve weeks to show any meaningful effect, and even then, research suggests that fewer than one in three patients achieves full remission with their first medication.
For people with treatment-resistant depression, defined as depression that has not responded to at least two adequate medication trials, the options offered by conventional medicine are limited and slow.
Ketamine is different in a fundamental way. Rather than targeting serotonin pathways, it works on the glutamate system, and it does so fast. Researcher Elizabeth Ballard, PhD of the National Institute of Mental Health published findings showing that ketamine can reduce depressive symptoms, including suicidal ideation, within hours of a single infusion, and it does so independently of its effects on mood stabilization. That speed and mechanism represent a genuine shift in how depression can be approached.
At BioFuse, ketamine infusions for depression are administered intravenously under continuous medical supervision, following clinically grounded protocols designed for safety and lasting therapeutic benefit.
How Ketamine Works on the Depressed Brain
Depression involves more than low serotonin. Chronic stress, trauma, and prolonged depressive episodes cause structural damage in the brain, particularly in regions that regulate mood, decision-making, and emotional memory. Ketamine addresses this at a neurobiological level in ways that standard antidepressants cannot.
NMDA Receptor Blockade
Ketamine blocks NMDA receptors, interrupting an overactive glutamate signaling cycle that is commonly elevated in people with depression. This blockade reduces the neural "noise" associated with rumination, hopelessness, and negative cognitive patterns.
Rapid Synaptic Repair
Following NMDA blockade, ketamine triggers a burst of synaptic activity that promotes the rapid formation of new neural connections, particularly in the prefrontal cortex. This is one of the primary reasons patients often notice a shift in mood, mental clarity, or outlook within hours of a session, not weeks.
BDNF and Neurogenesis
Ketamine stimulates the production of Brain-Derived Neurotrophic Factor (BDNF), a protein essential for the growth and maintenance of neurons. Chronic depression is associated with reduced BDNF levels and measurable shrinkage in the hippocampus and prefrontal cortex. Ketamine's ability to restore BDNF activity and promote neurogenesis in these regions is one of its most significant and well-documented mechanisms.
Default Mode Network Reset
In people with depression, the Default Mode Network (DMN) tends to be locked in a state of excessive self-referential processing, the mental loop of self-criticism, guilt, and hopelessness that many depressed patients describe as impossible to turn off. Ketamine disrupts this pattern, allowing the brain to access more flexible, adaptive thinking.
Anti-Inflammatory Action
Growing research links depression to elevated neuroinflammation. Ketamine's anti-inflammatory effects on the central nervous system may reduce the inflammatory burden that contributes to persistent depressive symptoms, particularly in patients who have not responded to standard treatment.
Who Is Ketamine Therapy for? Signs You May Be a Candidate
Ketamine therapy is not a first-line treatment for mild or situational depression. It is designed for people who have struggled with persistent depression that has not responded adequately to other approaches. You may be a candidate if:
-
You have been diagnosed with major depressive disorder, persistent depressive disorder, or bipolar depression
-
You have tried two or more antidepressant medications without achieving sustained relief
-
You experience significant impairment in daily life, relationships, or work due to depression
-
You have symptoms of anhedonia, meaning the loss of interest in things that once brought pleasure
-
You experience suicidal ideation or a persistent sense of hopelessness
-
You are seeking a faster-acting option while adjusting other treatments
-
A psychiatrist or primary care provider has recommended exploring alternative approaches
Every client at BioFuse completes a comprehensive medical and mental health evaluation before beginning ketamine therapy. The evaluation confirms candidacy, rules out contraindications, and establishes a personalized treatment plan.
Schedule a Discovery Call and See If You Qualify
Where to Get Ketamine Therapy for Depression in Michigan and Idaho
BioFuse offers clinically supervised ketamine infusion therapy at four locations across Michigan and Idaho. All locations are open Monday through Friday 9am to 7pm and Saturday through Sunday 9am to 3pm.
Ketamine Therapy in Grand Rapids, Michigan Address: 465 Fuller Ave NE Suite C, Grand Rapids, MI 49503 Visit now: Google Business Profile Phone: (616) 888-5006
Ketamine Therapy in Portage, Michigan Address: 7097 S Westnedge Ave, Portage, MI 49002 Visit now: Google Business Profile Phone: (269) 686-6185
Ketamine Therapy in Traverse City, Michigan Address: 540 S Garfield Ave, Traverse City, MI 49686 Visit now: Google Business Profile Phone: (231) 645-9123
Ketamine Therapy in Boise, Idaho Address: 7610 W State St #125, Boise, ID 83714 Visit now: Google Business Profile Phone: (208) 484-7200
What the BioFuse Ketamine Treatment Experience Looks Like
Initial Consultation: A licensed BioFuse provider reviews your health history, psychiatric background, current medications, and treatment goals before any infusion is scheduled.
The Induction Series: BioFuse's research and data-driven protocol includes six IV ketamine sessions scheduled over two weeks, referred to as the Induction Series. This series is designed to produce breakthrough results and establish a neurological foundation for sustained benefit.
During the Infusion: Each session lasts approximately 60 minutes. Vital signs are monitored continuously throughout. Many patients report a sense of mental distance from their usual depressive thought patterns, a temporary dissociative state that many describe as profoundly therapeutic in itself.
Post-Session Reflection: Reflection and integration are built into the BioFuse approach. Processing what surfaces during and after sessions is an important part of how ketamine produces lasting change, not just temporary symptom relief.
Maintenance Infusions: After the Induction Series, most clients continue with maintenance infusions scheduled at a frequency tailored to their individual needs and response.
Medical Oversight at BioFuse
Every ketamine session at BioFuse is administered under the supervision of Medical Director Justin Houseman, MD, a Board-Certified Emergency Medicine Physician with more than a decade of clinical experience. The program is also supported by Dana, RN BSN, BioFuse's Ketamine Coordinator and Director of Education, who oversees patient experience and protocol excellence across all locations.
BioFuse follows rigorously tested, evidence-based clinical protocols. All medications are dispensed through licensed, regulated, U.S.-based pharmacies. No session proceeds without a full clinical evaluation, and every client is monitored throughout treatment.
Ready to Take the First Step?
If depression has been limiting your life and conventional treatments have not delivered lasting relief, ketamine therapy may open a path forward. The first step is a conversation with our clinical team to see if you qualify.
Schedule a Discovery Call and See If You Qualify
Want to learn more first? Explore Ketamine Therapy at BioFuse or consider starting with Precision Wellness Testing to get a complete picture of your health before beginning any new program.
FAQs
Q: How many ketamine sessions do I need for depression? BioFuse's protocol starts with an Induction Series of six IV ketamine sessions scheduled over two weeks. This structured series is designed to produce meaningful, lasting neurological change. After completing the Induction Series, most clients continue with maintenance infusions at a frequency tailored to their individual response and ongoing needs.
Q: How quickly will I feel results from ketamine for depression? Many clients report a noticeable shift in mood, mental clarity, or outlook within hours of their first session. This is one of the most significant differences between ketamine and conventional antidepressants, which typically take six to twelve weeks to show any benefit. Individual responses vary, and the full therapeutic effect typically builds across the Induction Series.
Q: Can I stay on my antidepressants while doing ketamine therapy? This is reviewed during your initial consultation with a BioFuse provider. Many clients continue their existing medications during ketamine therapy, but medication interactions and timing are assessed on an individual basis. You should not make changes to your current prescriptions without guidance from your prescribing provider.
Q: Does insurance cover ketamine therapy for depression? Ketamine treatments are not currently covered by insurance. BioFuse's Ketamine Induction Series is available at a set investment reviewed at time of consultation.
Q: Is ketamine therapy for depression a permanent fix? Ketamine therapy is not a cure, and results vary from person to person. Many clients experience meaningful and sustained relief following the Induction Series, particularly when combined with other supportive care. Maintenance infusions are available for clients who benefit from ongoing sessions to sustain their results.
Q: Do I need a referral from my psychiatrist to start? No referral is required to begin the process at BioFuse. A physician's referral is not needed, though BioFuse does recommend that your primary care provider or psychiatrist be informed of your plans to pursue ketamine therapy.
Q: What happens if ketamine therapy does not work for my depression? Not every patient responds to ketamine therapy. This is one of the reasons BioFuse conducts a thorough evaluation before beginning treatment. If results are limited, your care team will discuss your options and next steps based on your individual situation.
Q: Is ketamine therapy safe for people with suicidal ideation? This is an important clinical question that is addressed directly during the consultation process. Research, including work published by the National Institute of Mental Health, has shown that ketamine can reduce suicidal ideation rapidly and independently of its broader effects on depression. However, candidacy for ketamine therapy in the context of active suicidal ideation is evaluated on an individual basis by the BioFuse medical team.
The services offered at BioFuse are for general wellness purposes only and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. None of BioFuse's services are approved by the U.S. Food and Drug Administration (FDA) to treat or cure any medical conditions. All therapies are administered under the supervision of licensed medical professionals and are intended to support general health and wellness. Individual results may vary. Always consult with a qualified healthcare provider before beginning any new wellness program or therapy.